Howe & Rusling Inc. bought a new position in Invesco Pharmaceuticals ETF (NYSEARCA:PJP – Free Report) during the third quarter, Holdings Channel reports. The firm bought 556 shares of the company’s stock, valued at approximately $48,000.
Other institutional investors also recently bought and sold shares of the company. Envestnet Asset Management Inc. boosted its holdings in Invesco Pharmaceuticals ETF by 87.7% during the second quarter. Envestnet Asset Management Inc. now owns 23,878 shares of the company’s stock worth $1,963,000 after buying an additional 11,156 shares in the last quarter. HBW Advisory Services LLC purchased a new stake in shares of Invesco Pharmaceuticals ETF during the 3rd quarter worth about $509,000. &PARTNERS acquired a new stake in shares of Invesco Pharmaceuticals ETF during the 2nd quarter valued at about $308,000. Secure Asset Management LLC purchased a new position in shares of Invesco Pharmaceuticals ETF in the 3rd quarter valued at about $229,000. Finally, Northwestern Mutual Wealth Management Co. increased its position in shares of Invesco Pharmaceuticals ETF by 49.7% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 6,826 shares of the company’s stock valued at $561,000 after buying an additional 2,266 shares in the last quarter.
Invesco Pharmaceuticals ETF Stock Performance
Shares of NYSEARCA PJP opened at $84.68 on Thursday. The firm has a fifty day moving average of $86.95 and a 200 day moving average of $84.56. The firm has a market cap of $287.05 million, a PE ratio of 21.48 and a beta of 0.61. Invesco Pharmaceuticals ETF has a one year low of $69.53 and a one year high of $89.87.
Invesco Pharmaceuticals ETF Company Profile
PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.
Featured Articles
- Five stocks we like better than Invesco Pharmaceuticals ETF
- Do ETFs Pay Dividends? What You Need to Know
- Target Results Are Not a Retail Bellwether: Why the Dip Is a Buy
- How to Invest in Small Cap Stocks
- Williams-Sonoma Stock: Buy It and Never Let It Go
- Technology Stocks Explained: Here’s What to Know About Tech
- 5 Dividend ETFs to Buy and Hold Forever
Want to see what other hedge funds are holding PJP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Invesco Pharmaceuticals ETF (NYSEARCA:PJP – Free Report).
Receive News & Ratings for Invesco Pharmaceuticals ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesco Pharmaceuticals ETF and related companies with MarketBeat.com's FREE daily email newsletter.
